IL6 and brain neoplasm: In the context of brain tumors, although resident antigen-presenting microglia express TLRs, they are unable to secrete interleukin (IL)-1B, IL-6, or tumor necrosis factor-alpha (TNF-α) to mount an effective innate immune response [41].